Suppr超能文献

已发表模型的外部验证与更新:用于预测急性缺血性卒中接受阿替普酶治疗后有症状性颅内出血的7天风险的回顾性队列研究

External Validation and Updating of Published Models for Predicting 7-day Risk of Symptomatic Intracranial Hemorrhage after Receiving Alteplase for Acute Ischemic Stroke: A Retrospective Cohort Study.

作者信息

Chawalitpongpun Phaweesa, Sonthisombat Paveena, Piriyachananusorn Napacha, Manoyana Natthakarn

机构信息

Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.

The College of Pharmacotherapy of Thailand, The Pharmacy Council of Thailand, Nonthaburi, Thailand.

出版信息

Ann Indian Acad Neurol. 2024 Jan-Feb;27(1):58-66. doi: 10.4103/aian.aian_837_23. Epub 2024 Feb 6.

Abstract

BACKGROUND

Prediction scores for symptomatic intracranial hemorrhage (sICH) in acute ischemic stroke patients receiving thrombolytic therapy have been widely developed, but the external validation of these scores, especially in the Thai population, is lacking. This study aims to externally validate existing models and update the selected model to enhance its performance in our specific context.

METHODS

This cohort study retrospectively collected data from medical records between 2013 and 2022. Acute ischemic stroke patients who received thrombolysis were included. All predictors were gathered at admission. External validation was performed on eight published prediction models; in addition, the observed and expected probabilities of sICH were compared. The most effective model for discrimination was then chosen for further updating using multivariable logistic regression and was bootstrapped for internal validation. Finally, a points-based system for clinical practice was developed from the optimism-corrected model.

RESULTS

Fifty patients (10% of the 502 included cohort members) experienced sICH after undergoing thrombolysis. The SICH score outperformed the other seven models in terms of discrimination (area under the receiver operating characteristic [AuROC] curve = 0.74 [95% confidence interval {CI} 0.67 to 0.81]), but it still overstated risk (expected-to-observed outcomes [E/O] ratio = 1.7). Once updated, the optimism-corrected revised SICH model showed somewhat better calibration (E/O = 1 and calibration-in-the-large = 0), slightly worse underprediction in the moderate-to-high risk group (calibration slope = 1.152), and marginally better discrimination (AuROC = 0.78). The points-based system also demonstrated substantial agreement (88.1%) with the risk groups predicted by the logistic regression model (kappa statistic = 0.78).

CONCLUSION

Since the SICH score outperformed seven models in terms of discrimination, it was then modified to the Revised-SICH score, which predicted that patients with at least 5.5 points were at high risk of having sICH.

摘要

背景

针对接受溶栓治疗的急性缺血性卒中患者的症状性颅内出血(sICH)预测评分已广泛开发,但这些评分的外部验证,尤其是在泰国人群中的验证尚缺。本研究旨在对现有模型进行外部验证,并更新所选模型以提高其在我们特定背景下的性能。

方法

这项队列研究回顾性收集了2013年至2022年的病历数据。纳入接受溶栓治疗的急性缺血性卒中患者。所有预测因素均在入院时收集。对八个已发表的预测模型进行外部验证;此外,比较了sICH的观察概率和预期概率。然后选择最有效的鉴别模型,使用多变量逻辑回归进行进一步更新,并进行自抽样以进行内部验证。最后,从经乐观校正的模型开发出基于积分的临床实践系统。

结果

50例患者(纳入队列的502名成员中的10%)在接受溶栓治疗后发生了sICH。SICH评分在鉴别方面优于其他七个模型(受试者操作特征曲线下面积[AuROC]=0.74[95%置信区间{CI}0.67至0.81]),但仍高估了风险(预期与观察结果[E/O]比值=1.7)。更新后,经乐观校正的修订SICH模型显示校准稍好(E/O=1且总体校准=0),中高风险组的预测不足稍差(校准斜率=1.152),鉴别能力略好(AuROC=0.78)。基于积分的系统与逻辑回归模型预测的风险组也显示出高度一致性(88.1%)(kappa统计量=0.78)。

结论

由于SICH评分在鉴别方面优于七个模型,因此将其修改为修订SICH评分,该评分预测至少5.5分的患者发生sICH的风险较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/10941888/613ea44f4dce/AIAN-27-58-g002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验